Veli3 Activators
Veli3 (LIN7C) activators are a class of compounds that facilitate the functional involvement of the Veli3 protein in its associated cellular pathways. These chemicals, rather than directly interacting with Veli3, predominantly affect cellular processes and pathways where Veli3 has a critical role, thus enhancing its functional relevance. For instance, Forskolin, by bolstering cAMP levels, indirectly promotes Veli3's involvement in synaptic vesicle exocytosis. Similarly, agents like Nifedipine modify calcium dynamics, consequently facilitating Veli3's role in synaptic processes.
On the other hand, compounds such as Bafilomycin A1 and Wortmannin affect vesicular trafficking, thereby indirectly promoting pathways in which Veli3 operates. The influence of these activators on various cellular processes, from cytoskeletal dynamics to signal transmission, underscores the pivotal role Veli3 plays across different cellular contexts. As these chemicals modulate diverse pathways, they collectively highlight the multifaceted involvement of Veli3 (LIN7C) in maintaining cellular homeostasis and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By stimulating adenylate cyclase and increasing cAMP levels, Forskolin can bolster synaptic vesicle exocytosis, indirectly promoting Veli3 (LIN7C) association in the process. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC). Active PKC can modulate processes in which Veli3 (LIN7C) is crucial, thereby encouraging its function. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Though primarily an inhibitor of vacuolar ATPase, by impacting vesicular trafficking, Bafilomycin A1 indirectly activates pathways where Veli3 (LIN7C) operates. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
By disrupting actin polymerization, Latrunculin A can activate pathways that rely on Veli3 (LIN7C), particularly in vesicle exocytosis. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
As a PI3 kinase inhibitor, Wortmannin can promote vesicular trafficking pathways where Veli3 (LIN7C) is an integral participant. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
By inhibiting phosphatases, Okadaic acid affects phosphorylation dynamics, potentially enhancing pathways that involve Veli3 (LIN7C). | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
An agent that destabilizes microtubules. By affecting cytoskeletal dynamics, Nocodazole can activate pathways requiring Veli3 (LIN7C)'s role. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
An inhibitor of Ras farnesyltransferase, its action can indirectly enhance pathways where Veli3 (LIN7C) is involved in signal transmission. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, Genistein can activate certain signaling pathways where Veli3 (LIN7C) plays an integral role. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
By inhibiting actin polymerization, it indirectly supports the functional roles of Veli3 (LIN7C) in vesicle trafficking. | ||||||